128 related articles for article (PubMed ID: 7019505)
1. [Lipid metabolism and the arterial wall].
Kuzuya F
Nihon Rinsho; 1980 Sep; 38(9):3149-55. PubMed ID: 7019505
[No Abstract] [Full Text] [Related]
2. [Lipid metabolism in arterial walls and development of atheroma].
Nikkari T
Duodecim; 1977; 93(10):727-43. PubMed ID: 872780
[No Abstract] [Full Text] [Related]
3. [Role of lipoproteins in the etiology of arteriosclerosis].
Cybulska B; Szostak WB
Kardiol Pol; 1981; 24(5):387-96. PubMed ID: 7021946
[No Abstract] [Full Text] [Related]
4. [Arteriosclerosis. I. Pathogenesis of atheromatous focus].
Szostak WB; Kłosiewicz-latoszek L; Cybulska B
Wiad Lek; 1985 Jul; 38(14):1031-7. PubMed ID: 3907148
[No Abstract] [Full Text] [Related]
5. Pathogenetic mechanisms in atherosclerosis.
Walton KW
Am J Cardiol; 1975 Apr; 35(4):542-58. PubMed ID: 164110
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis.
Gryglewski RJ; Szczeklik A
Mater Med Pol; 1978; 10(4):338-41. PubMed ID: 113631
[No Abstract] [Full Text] [Related]
7. [Prostaglandins and arteriosclerosis].
Livshits IB; Mrochek AG; Tiabut TD
Patol Fiziol Eksp Ter; 1983; (2):80-4. PubMed ID: 6343982
[No Abstract] [Full Text] [Related]
8. Vascular disease in diabetes: pathophysiological mechanisms and therapy.
Colwell JA; Halushka PV; Sarji KE; Lopes-Virella MF; Sagel J
Arch Intern Med; 1979 Feb; 139(2):225-30. PubMed ID: 434977
[No Abstract] [Full Text] [Related]
9. [The biochemical bases of the pathogenesis of arteriosclerosis].
Klimov AN; Loviagina TN
Patol Fiziol Eksp Ter; 1966; 10(2):3-9. PubMed ID: 4870457
[No Abstract] [Full Text] [Related]
10. [HDL-cholesterol in cerebrovascular disease (author's transl)].
Murai A; Miyahara T; Udaka F
Rinsho Byori; 1981 Nov; 29(11):1095-100. PubMed ID: 7334663
[No Abstract] [Full Text] [Related]
11. [Blood serum levels of cholesterol, HDL-cholesterol and triglycerides in diseases of the cerebrovascular circulation].
Szirmai I; Fendler K; Gömöri E
Orv Hetil; 1988 Jun; 129(25):1307-11. PubMed ID: 3194125
[No Abstract] [Full Text] [Related]
12. [Biochemistry of atherogenesis: effects of prostaglandins (author's transl)].
Dousset JC
Pathol Biol (Paris); 1981 Jan; 29(1):53-61. PubMed ID: 7010278
[TBL] [Abstract][Full Text] [Related]
13. [Disturbances of metabolism of high density lipoproteins in patients with ischemic stroke].
Aĭtbaev KA
Vopr Med Khim; 1982; 28(6):48-50. PubMed ID: 6961612
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies.
Sinzinger H; Rogatti W
J Physiol Pharmacol; 1994 Mar; 45(1):27-40. PubMed ID: 8043908
[TBL] [Abstract][Full Text] [Related]
15. [Lipid metabolism disorders in patients with retinal artery occlusions].
Fellinger C; Schmut O; Hofmann H
Klin Monbl Augenheilkd; 1984 Feb; 184(2):109-11. PubMed ID: 6716886
[TBL] [Abstract][Full Text] [Related]
16. [HDL--the unknown with great significance].
Mordasini R; Riesen W; Oster P
Schweiz Med Wochenschr; 1981 Feb; 111(9):309-14. PubMed ID: 7221532
[TBL] [Abstract][Full Text] [Related]
17. [Kinetics of cellular elements of the vascular wall in atherosclerosis].
Nagornev VA
Arkh Patol; 1988; 50(10):86-95. PubMed ID: 3064737
[TBL] [Abstract][Full Text] [Related]
18. [Serum lipid and lipoprotein changes in patients of cerebrovascular diseases (author's transl)].
Li JZ
Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):142-5. PubMed ID: 6809257
[No Abstract] [Full Text] [Related]
19. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
Bruck J; Fischer M; Tschabitscher H
Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
[TBL] [Abstract][Full Text] [Related]
20. [Disorders of lipid metabolism in essential arterial hypertension in young people].
Bărbulescu A; Suţeanu S
Med Interna (Bucur); 1973 Jun; 25(6):711-24. PubMed ID: 4793942
[No Abstract] [Full Text] [Related]
[Next] [New Search]